The present invention relates to formulations comprising combinations ofanalgesic/anti-inflammatory, immunomodulating and cartilage-reconstructingagents in particular comprising saligenig, boswellic acid, procyanidins, N-acety-glucosamine and either glucoronic acid or glucoronolactone, for thetreatment of rheumatoid arthritis and, more generally, of arthritis conditions.